FDA advisors unanimously vote to approve Moderna’s mRNA after agency drama
An FDA advisory committee has unanimously recommended the approval of Moderna's mRNA influenza vaccine for older adults.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A federal vaccine panel voted unanimously to recommend the authorization of Moderna’s mRNA-based flu vaccine. This decision marks the first time such an advisory committee has recommended a vaccine since 2023. The shot is intended for use in older adult populations.
Coverage from CIDRAP, NPR, Stat News, FirstWord Pharma, WRAL, NBC News, and Ars Technica emphasizes the unanimous nature of the vote. Reports also note that the approval process followed a period of agency drama and controversy surrounding the vaccine. Next steps involve the formal FDA regulatory process following this panel endorsement.
Coverage does not yet specify a final timeline for the vaccine's availability.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 43d ago.
Quick answers
Who is the vaccine for?
According to NBC News, the vaccine is intended for older adults.
What technology does the vaccine use?
The vaccine utilizes mRNA technology, described by reporting as first-of-its-kind for a flu shot.
Was the committee vote divided?
No, multiple outlets including Ars Technica and NPR report the vote was unanimous.
Coverage (7)
- Moderna’s mRNA flu vaccine gets thumbs up from federal vaccine panel CIDRAP · 45d ago
- Key FDA committee unanimously recommends its first vaccine since 2023 NPR · 45d ago
- FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy statnews.com · 45d ago
- FDA panel strongly backs Moderna's mRNA flu vaccine FirstWord Pharma · 45d ago
- FDA panel considers a first-of-its-kind flu vaccine using mRNA technology WRAL · 45d ago
- FDA panel recommends Moderna’s mRNA flu shot for older adults NBC News · 45d ago
- FDA advisors unanimously vote to approve Moderna’s mRNA after agency drama Ars Technica · 45d ago
Topics
Related trends
FDA Panel Backs 6 Peptides for Compounding
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Nearly 12 million bottles of Rohto eye drops over sterility concerns, FDA announces
The FDA announces a recall of nearly 12 million bottles of Rohto eye drops due to sterility concerns.
Fruit sold at Publix sickens multiple people in 8 states
Publix has expanded a multi-state recall of frozen berries after an E. coli outbreak sickened 12 people across eight states.
Replimune’s twice-rejected melanoma drug prevails in FDA adcomm
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
New, more efficient pill to lower cholesterol
FDA approves first oral PCSK9 inhibitor for adults with high cholesterol, changing treatment options.
FDA Panel Votes In Favor of Replimune’s Melanoma Treatment
Replimune shares surge following a favorable FDA advisory panel vote for its melanoma treatment.